Short Interest in Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Declines By 57.6%

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totalling 32,500 shares, a drop of 57.6% from the March 15th total of 76,600 shares. Based on an average daily trading volume, of 447,500 shares, the short-interest ratio is presently 0.1 days.

Ono Pharmaceutical Stock Up 4.4 %

OTCMKTS OPHLY opened at $4.01 on Wednesday. The business’s fifty day moving average is $3.61 and its two-hundred day moving average is $3.74. Ono Pharmaceutical has a 1 year low of $3.21 and a 1 year high of $5.20.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.